Doctors, drugmakers call for broader scope of marketing activities

Doctors and pharmaceutical companies have recently called on the government to revise regulations relating to the system that they called ”ambiguous“ in distinguishing between legal and illegal marketing acts.

In a forum hosted by the Korean Medical Association (KMA) on Friday, a local lawyer Hyun Doo-ryun said that the government should come up with a plan to revise the flawed guideline for...